Unibest

Pharmaceutical intermediates

Treprostinil Intermediates

7 pharmaceutical intermediates for Treprostinil. Indication: Interstitial Lung Disease ; Pulmonary Hypertension; Pulmonary Arterial Hypertension.

提交项目All intermediates

About Treprostinil

Originator
United Therapeutics Corporation
Indication
Interstitial Lung Disease ; Pulmonary Hypertension; Pulmonary Arterial Hypertension
Approved Date
09/28/2023
DS/DP
03/29/2028

Available intermediates

7 intermediates currently listed for Treprostinil. Request specifications, documentation or a quotation for any item below.

Treprostinil intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
(1R,2R,3aS,9aS)-2,3,3a,4,9,9a-Hexahydro-1-[(3S)-3-hydroxyoctyl]-1H-benz[f]indene-2,5-diol101692-02-8//
1-broMo-5-fluoro-2-Methyl-3-nitrobenzene502496-33-5//
methyl 4-cyclopropyl-2-fluorobenzoate1613413-65-2//
tert-butyl 2-(4-amino-6-chloropyrimidin-5-yloxy)ethylmethylcarbamate1787294-51-2//
2H-Benz[f]inden-2-one, 9-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-3,3a,4,9-tetrahydro-5-methoxy-1-[(3S)-3-[(tetrahydro-2H-pyran-2-yl)oxy]octyl]-, (3aS,9R)-223734-60-9//
2-allyl-3-methoxybenzaldehyde94956-98-6//
(5S)-1-Decyn-5-ol848609-05-2//

Other programs under T

Tazemetostat HydrobromideTazobactam SodiumTegoprazanTenapanor HydrochlorideTeneligliptinTetrabenazineTezacaftorTianeptine sodium salt

Building toward Treprostinil?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →